Lupin enters prescription dermatology segment in Brazil
Valued at USD 28 billion, Brazil is the world's sixth largest pharmaceutical market, driven by growing public health expenditure and increasing household income.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Brazil Health | Dermatology | Expenditures | International Medicine & Public Health | Pharmaceuticals | Skin